Bladder Cancer
Bladder Cancer
Bladder Cancer
Some Facts
Bladder cancer is the fifth most common cancer in men, but only half as common in women.
While it can occur at any age, even in children, it is rare under the age of 50 years.
More than 90% of bladder cancers form in the lining of the bladder (the urothelium) and are
known as urothelial carcinomas, or transitional cell carcinomas.
Other types of bladder cancers, including squamous cell carcinomas and adenocarcinomas, are
rare in Australia.
Around 75% of bladder cancers are superficial (confined to the inner lining) and treatment is
relatively simple, but in 25% of cases the cancer has invaded the bladder wall and partial or
complete removal of the bladder is necessary, or alternatively radiation therapy with or without
chemotherapy.
This fact sheet was commissioned by the Urological Society of Australia and New Zealand
www.usanz.org.au
MF/AOD1302
How is bladder cancer treated?
The treatment will vary, depending on whether the cancer is invasive or not.
The cytoscope is used to cut the cancer out (transurethral resection) under a general anaesthetic. The
tissue removed will be sent to a pathologist who will examine the specimen microscopically to
determine if the cancer is just in the lining of the bladder, partially invading the wall of the bladder, or
more deploy invading the muscle of the bladder wall. In the first scenario the tumours may recur, but
rarely spread to other parts of the body and hence are rarely fatal. In the latter scenario, namely
invasive cancers, the cancer can spread and may be fatal if left untreated so aggressive therapies are
required.
Superficial cancer: as the tumours frequently recur, the patient will need regular review, undergoing
repeat check-up cystoscopies under local anaesthetic for up to a decade.
Chemotherapy is not routinely required for superficial cancer. However if there are many tumours
or they appear particularly aggressive, chemotherapy or immunotherapy may be advised. This is a
drug delivered in a fluid by putting a catheter into the bladder once a week for six weeks
(intravesical chemotherapy). No anaesthetic is needed and it can be done in an outpatient setting.
Systemic chemotherapy (a drug delivered through the bloodstream) is usually only used in patients
with advanced disease.
Invasive cancer:
Partial or complete removal of the bladder, known as cystectomy, may be required. Following a
cystectomy the urine needs to be diverted in one of the following ways:
o Urine is directed through the intestinal tissue, known as an ileal conduit, with an opening or
“stoma” on the abdominal wall. The patient will wear a pouch externally on the skin to
collect urine; or
o An orthotopic neobladder is created. In this operation the patient’s bladder is removed and
replaced with loops of their own bowel, fashioned into a pouch. There is no change to
normal bowel function and the patient passes urine naturally through the urethra.
Surgery:
The side-effects from bladder removal are substantial and life-changing.
Men face impotence and infertility:
o Most men who have the operation will be impotent because the nerves to the penis
become damaged.
o Bladder removal also means infertility. Men can no longer ejaculate as the prostate has
to be removed as well to limit the spread of the cancer.
This fact sheet was commissioned by the Urological Society of Australia and New Zealand
www.usanz.org.au
MF/AOD1302
Women also face sexual dysfunction and sometimes infertility:
o Part of the interior vaginal wall may be removed along with the bladder. This leads to a
shortening or narrowing of the vagina which can cause discomfort during sex.
o In some cases the ovaries, Fallopian tubes and uterus are removed as well leading to
immediate menopause with symptoms such as hot flushes, vaginal dryness and
insomnia. Women are then infertile.
A hernia can develop alongside the ileal conduit/stoma that may be unsightly and may require
repair.
If a neobladder is constructed this reduces any body image stresses and eliminates the risks of
hernias alongside the conduit however the formation of the neobladder can lead to
incontinence , and the need to empty the new bladder via a catheter rather than naturally and
these risks need to be discussed with patients clearly beforehand .
www.cancercouncil.com.au
www.healthinsite.gov.au
This fact sheet was commissioned by the Urological Society of Australia and New Zealand
www.usanz.org.au
MF/AOD1302